• Facebook
  • Instagram
  • Twitter

Get Support – Call 1-888-MITO-411

  • Shop
  • Events
  • Donate
  • Search
MitoAction

MitoAction

Support, Education, Outreach and Advocacy for Children and Adults Living with Mitochondrial Disease

  • Mitochondrial Disease
    • About Mito
      • New Patient Kit
      • Types of Mitochondrial Diseases
      • Symptoms of Mito
      • Treatment for Mito
      • Diagnosing Mito
      • Mito FAQs
    • Diagnosis & Care
      • Mitochondrial Disease Diagnosis
      • Find a Mito Doctor
      • Mito Disease Treatment
      • Mito Cocktail
      • Clinical Trials & Studies
    • Day to Day with Mito
      • Mito Life Hacks
      • Mito Resources
      • Living with Mitochondrial Disease
      • Care Coordination & Management
      • Managing Your Energy
      • Traveling with Mito
    • For Medical Professionals
      • Mitochondrial Care Network
      • Monthly Expert Series
  • Fatty Acid Oxidation Disorders
    • About FAODs
      • Types of FAODs
      • Symptoms of FAODs
      • Diagnosing FAODs
      • Treatment for FAODs
    • FAOD Programs & Support
      • New Patient Kit
      • FAOD Support Calls
      • FAOD Experts Series
      • International Metabolic Conference
    • Day to Day with FAOD
      • FAOD Resources
      • FAOD Life Hacks
  • Programs & Support
    • Patient & Family Support
      • Mito411
      • Support Calls
      • MitoAction Memories
      • MitoPlaydates
      • MitoSocials
      • Become a MitoChampion
      • Positive Peach Packages
      • Liney’s Lovies
    • MitoAction Programs
      • Dalia’s Wish
      • Matthew Harty Camper Fund & Scholarship
      • Marcel’s Way Family Fund
      • MitoArtisan’s Playtime
      • MitoSantas
      • MyMito App
    • Education
      • Monthly Expert Series
      • Wondering Wednesdays
      • Energy In Action Podcast
      • Energy 4 Education
      • Patient Education Forums
      • International Metabolic Conference
    • Planning & Preparation
      • Health Insurance
      • Disability Benefits
      • Mobility Devices
      • Vehicle Modification
      • Estate Planning
      • Medical Child Abuse
  • Join the Cause
    • Giving
      • Donate to MitoAction
      • Honor and Memorial Giving
      • Matching Gifts
      • Another Helping
      • Giving Tuesday
      • Shop for MitoAction
    • Events
      • Events Calendar
      • International Metabolic Conference
      • MitoAction Energy Walks
      • Sandra K. Russell Derby Day Benefit for Mito
      • Matthew Harty Camper Fund Events
    • Volunteer
      • Host a MitoSocial
      • Host a MitoPlaydate
      • Create a Fundraiser
      • Become a MitoChampion
      • Share Your Ideas
    • Raise Your Voice
      • Take Legislative Action
      • Mitochondrial Disease Awareness Week
      • Open Mito Mic & Art Show
      • MitoAction Memories
  • About MitoAction
    • Contact Us
    • Connect on Social
    • Our Team
    • Meet Our Partners
    • Newsletter Signup
  • Show Search

MitoAction Advocates for Barth Syndrome Community in FDA Listening Session

mitoaction Apr 1, 2024

Print Friendly, PDF & Email

FOR IMMEDIATE RELEASE

[Boston, MA, April 1, 2024] – MitoAction, a leading nonprofit organization dedicated to improving the lives of individuals and families affected by mitochondrialRelated to the mitochondria. disease, recently convened a pivotal FDA listening session on March 22nd, 2024. This session served as a crucial platform for MitoAction to underscore the persistent unmet needs and ongoing challenges faced by the Barth syndromeA rare, genetic disorder of lipid metabolism that primarily affects males. community.

Barth syndrome is an ultra-rare, life-threatening genetic disorder characterized by cardiac and skeletal muscle weakness, as well as immune system dysfunction. Individuals living with Barth Syndrome and their families continue to confront significant obstacles in accessing appropriate care and therapies.  There are currently no FDA approved therapies for Barth syndrome.

The FDA listening session organized by MitoAction provided an invaluable opportunity for stakeholders within the Barth syndrome community to engage directly with regulatory authorities. During the session, participants, who included Key Opinion Leaders and moms of boys diagnosed with this rare disorder, shared compelling insights into the lived experiences of individuals affected by Barth syndrome, highlighting the urgent need for accelerated research and expanded treatment options.

“MitoAction remains steadfast in our commitment to advocating for the Barth syndrome and the entire mitochondrial disease community,” said Kira Mann, CEO at MitoAction. “Our recent FDA listening session was a pivotal moment for amplifying the voices of those affected by this devastating condition. By fostering dialogue and collaboration with the Barth Syndrome Foundation and the FDA, we are working tirelessly to drive positive change and improve outcomes for individuals living with Barth syndrome.”

Through collaborative efforts with regulatory agencies like the FDA, MitoAction continues to champion initiatives aimed at advancing research, accelerating drug development, and enhancing access to care for individuals and families affected by mitochondrial diseases, including Barth syndrome.

For more information about MitoAction and its advocacy efforts, please visit www.mitoaction.org

About MitoAction: MitoAction is a nonprofit organization dedicated to improving the quality of life for individuals and families affected by mitochondrial disease through support, education, advocacy, and clinical research initiatives. Since its founding in 2005 MitoAction has been at the forefront of empowering the mitochondrial disease community and driving positive change in the field of mitochondrial medicine.  MitoAction serves families from across the U.S. and the globe, working tirelessly to offer comprehensive, up-to-date, expert resources, information, and support at no cost to any patient, family, clinician, educator, or community member. Learn more at www.mitoaction.org.

Press Contact

Kira Mann, CEO, MitoAction

E-mail: kira@mitoaction.org

www.mitoaction.org

Press-Release-FDA-Lisitenting-Session-Barth-Syndromw.docx

Mitochondrial Disease News barth syndrome, fda

Upcoming Events

View All
May 21
7:00 pm

MitoChampions Meeting

May 22
12:00 pm - 1:00 pm

FAOD Support: Exploring the Younger Years

May 23
12:00 pm

Weekly Support Call

View Calendar

Expert Series

View All
There are no upcoming events.

Last Presentation

Expert Series: Serial Casting and Toe Walking
Presented April 25, 2025

P.O. Box 310
Novi, MI 48376
(888) 648-6228
info@mitoaction.org

  • Support
  • Resources
  • Donate to MitoAction
  • Events
  • Subscribe
©2025 MitoAction. All Rights Reserved.

Privacy Policy. Terms of Use.